The CT-Luso Project coordination team held its 22nd progress meeting by videoconference on 1 July, focusing on the current status of the training programme, the project’s upcoming activities and the dissemination of the scientific results achieved so far.
At the opening of the meeting, Project Coordinator Hélder Mota Filipe presented a very positive assessment of the implementation of Work Package 5, highlighting the strong results achieved by trainees in the assessments conducted. A second assessment opportunity was also announced for participants who were unable to take part in the initial assessment, reaffirming the project’s commitment to ensuring that all trainees successfully complete the training programme.
It was also announced that the list of participants selected for the final level of training, the first to be delivered in person (WP6), will be published shortly. The partner institutions in each country will be responsible for nominating trainees in accordance with the quotas previously established.
The final training phase will take place in Lisbon from 8 to 14 November 2026, bringing together 28 trainees from the five partner countries. The provisional programme will be announced shortly and will involve several Portuguese institutions, including the Commission for Clinical Research Ethics (CEIC), INFARMED, I.P., NOVA Medical School and BlueClinical.
The meeting also included a review of the webinar ‘Equity in Access to Health Innovation’, held on 25 June, which brought together around 70 participants. Joana Morais, Director-General of the National Institute for Health Research of Angola, highlighted the high level of participation and the quality of the dialogue generated during the session, underlining the contribution of the initiative to strengthening knowledge and sharing experiences among the different partner countries.
Among the positive developments presented during the meeting was the acceptance of a scientific article by BERC-Luso, the predecessor project to CT-Luso, for publication in the journal Global Bioethics. This recognition highlights the relevance of the research carried out under the previous initiative and its continuity in the current project. According to Hélder Mota Filipe, the publication represents important validation from the international scientific community and a source of pride for all the partners involved.
The submission of a scientific abstract to the XV World Congress of Portuguese-Speaking Pharmacists, to be held from 25 to 27 November in Maputo, was also announced. If accepted, the work will be presented as a poster, further strengthening the project’s international visibility and the dissemination of its results.
The next CT-Luso Project coordination meeting is scheduled for 2 September.
